Brewin Dolphin LTD Abbott Laboratories Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Brewin Dolphin LTD holds 23,844 shares of ABT stock, worth $2.74 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

23,844

Previous 23,744 0.42%

Holding current value

$2.74 Million

Previous $2.81 Million 7.79%

% of portfolio

0.12%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 14, 2022	BUY	$102.07 - $123.37 $10,207 - $12,337	100 Added 0.42%	23,844 $2.59 Million
Q1 2022 Nov 14, 2022	SELL	$114.02 - $139.04 $11,516 - $14,043	-101 Reduced 0.42%	23,744 $2.81 Million
Q4 2021 Nov 14, 2022	BUY	$115.53 - $141.46 $2.75 Million - $3.37 Million	23,845 New	23,845 $3.36 Million
Q3 2021 Nov 09, 2023	SELL	$116.66 - $129.06 $232,386 - $257,087	-1,992 Reduced 6.26%	29,829 $3.52 Billion
Q2 2021 Nov 09, 2023	BUY	$105.79 - $124.53 $19,571 - $23,038	185 Added 0.58%	31,821 $3.69 Billion
Q1 2021 Nov 09, 2023	SELL	$108.84 - $128.23 $71,725 - $84,503	-659 Reduced 2.04%	31,636 $3.79 Billion
Q4 2020 Nov 09, 2023	BUY	$105.0 - $114.42 $45,150 - $49,200	430 Added 1.35%	32,295 $3.54 Billion
Q3 2020 Nov 09, 2023	SELL	$91.64 - $111.29 $1.13 Million - $1.37 Million	-12,351 Reduced 27.93%	31,865 $3.47 Billion
Q2 2020 Nov 09, 2023	BUY	$76.57 - $98.0 $28,101 - $35,966	367 Added 0.84%	44,216 $4.04 Billion
Q1 2020 Nov 09, 2023	SELL	$62.82 - $91.86 $5,653 - $8,267	-90 Reduced 0.2%	43,849 $3.46 Billion
Q4 2019 Nov 09, 2023	BUY	$78.51 - $87.4 $5,495 - $6,118	70 Added 0.16%	43,939 $3.82 Billion
Q3 2019 Nov 09, 2023	SELL	$81.84 - $88.74 $23,651 - $25,645	-289 Reduced 0.65%	43,869 $3.67 Billion
Q2 2019 Nov 09, 2023	SELL	$72.88 - $85.0 $6,413 - $7,480	-88 Reduced 0.2%	44,158 $3.71 Billion
Q1 2019 Nov 09, 2023	BUY	$66.22 - $80.06 $22,779 - $27,540	344 Added 0.78%	44,246 $3.54 Billion
Q4 2018 Nov 09, 2023	BUY	$65.56 - $74.27 $8,195 - $9,283	125 Added 0.29%	43,902 $3.18 Billion
Q3 2018 Nov 09, 2023	BUY	$60.81 - $73.36 $10,641 - $12,838	175 Added 0.4%	43,777 $3.21 Billion
Q2 2018 Nov 09, 2023	BUY	$57.57 - $63.54 $34,542 - $38,124	600 Added 1.4%	43,602 $2.66 Billion
Q1 2018 Nov 09, 2023	BUY	$56.27 - $63.62 $31,117 - $35,181	553 Added 1.3%	43,002 $2.58 Billion
Q3 2017 Nov 09, 2023	BUY	$48.06 - $53.64 $894,156 - $997,972	18,605	42,449 $2.27 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Account

Brewin Dolphin LTD Abbott Laboratories Transaction History